New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 25, 2014
10:07 EDTUFS, SVLC, MERC, ARIA, SHTDF, SOL, RAX, PANW, PCAR, EXA, E, SBMRYOn The Fly: Analyst Upgrade Summary
Domtar (UFS) upgraded to Buy from Neutral at Goldman... Eni SpA (E) upgraded to Outperform from Market Perform at Raymond James... Exa Corp. (EXA) upgraded to Outperform from Neutral at RW Baird... PACCAR (PCAR) upgraded to Buy from Neutral at Goldman... Palo Alto (PANW) upgraded to Outperform from Market Perform at FBR Capital... Rackspace (RAX) upgraded to Overweight from Equal Weight at Morgan Stanley... ReneSola (SOL) upgraded to Buy from Neutral at Roth Capital... Sinopharm Group (SHTDF) upgraded to Outperform from Neutral at Credit Suisse... ARIAD (ARIA) at H.C upgraded to Buy from Neutral at H.C. Wainwright... SilverCrest (SVLC) upgraded to Buy from Neutral at Roth Capital... Mercer (MERC) upgraded to Hold from Reduce at TD Securities... SABMiller (SBMRY) upgraded to Outperform from Market Perform at Bernstein.
News For UFS;E;EXA;PCAR;PANW;RAX;SOL;SHTDF;ARIA;MERC;SVLC;SBMRY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 29, 2014
14:21 EDTSBMRYEarnings Preview: Altria Group up more than 13% since Q2 report
Subscribe for More Information
October 28, 2014
10:52 EDTPANWIT security stocks climb after FireEye upgrade, Radware outlook
Subscribe for More Information
08:03 EDTPCARPACCAR reports Q3 EPS $1.04, consensus 96c
Subscribe for More Information
October 27, 2014
15:36 EDTPCARNotable companies reporting before tomorrow's open
Subscribe for More Information
10:00 EDTRAXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:42 EDTRAXRackspace upgraded at BofA/Merrill
Subscribe for More Information
06:53 EDTRAXRackspace upgraded to Buy from Neutral at BofA/Merrill
October 24, 2014
07:58 EDTSBMRYMolson Coors seen as winner if peers merge, Bloomberg says
Subscribe for More Information
07:37 EDTARIAARIAD announces CHMP adopts final opinion on Iclusig
ARIAD Pharmaceuticals announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted its final opinion on Iclusig following the recommendations made by the Pharmacovigilance Risk Assessment Committee earlier this month. The PRAC conducted an 11-month review of the available data on Iclusig and consulted with a scientific advisory group in oncology. This week, the EMA recommended that Iclusig continue to be used in accordance with its already approved indications as a treatment of certain leukaemias and confirmed that the benefit-risk profile of Iclusig continues to be positive in each of these indications. The EMA also recommended additional warnings in the European product information to minimize the risk of vascular events. The company said, "We are now well positioned to complete pricing and reimbursement negotiations in Europe and to ensure that Iclusig is available to appropriate Philadelphia-chromosome positive leukaemia patients."
October 23, 2014
11:43 EDTEEni SpA upgraded to Buy from Hold at Societe Generale
Subscribe for More Information
11:25 EDTUFSDomtar rallies after MLP conversion discussion on call
Shares of Domtar rallied during the company's earnings conference call as the possibility of a master limited partnership conversation was addressed. Domtar stated that if it feels it would have "something compelling in the marketplace," it could consider the possibility of an MLP. It added, "If there's something there that could create shareholder value, you'll see us doing something or sharing something with the market." Shares of Domtar are up 9% to $39.44 in late morning trading. The call is now over.
11:25 EDTPANWInternet security names climb after Check Point, Fortinet beat expectations
Subscribe for More Information
10:01 EDTMERCOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: 3D Systems (DDD) downgraded to Hold from Buy at Brean Capital... Angie's List (ANGI) downgraded to Hold from Buy at Needham... Avalon Rare Metals (AVL) downgraded to Neutral from Buy at Citigroup... Axiall (AXLL) downgraded at Cowen... BB&T (BBT) downgraded to Neutral from Buy at Goldman... Boeing (BA) downgraded at Credit Suisse... Boulder Brands (BDBD) downgraded to Hold from Buy at Canaccord... Citrix (CTXS) downgraded to Hold from Buy at Drexel Hamilton... ClickSoftware (CKSW) downgraded to Hold from Buy at Lake Street... DTS, Inc. (DTSI) downgraded to Underweight from Neutral at JPMorgan... GulfMark Offshore (GLF) downgraded to Market Perform from Outperform at Cowen... Home Loan Servicing (HLSS) downgraded to Neutral from Buy at Compass Point... ICON plc (ICLR) downgraded to Equal Weight from Overweight at First Analysis... IPC The Hospitalist Co. (IPCM) downgraded to Market Perform at Wells Fargo... Melco Crown (MPEL) downgraded to Neutral from Buy at Nomura... Mercer (MERC) downgraded at Credit Suisse... ONEOK Partners (OKS) downgraded to Neutral from Buy at BofA/Merrill... Owens Corning (OC) downgraded to Neutral from Overweight at JPMorgan... Regency Energy Partners (RGP) downgraded to Neutral from Buy at BofA/Merrill... The Medicines Co. (MDCO) downgraded to Neutral from Buy at BofA/Merrill... Tupperware Brands (TUP) downgraded to Neutral from Overweight at JPMorgan... Union Bankshares (UBSH) downgraded at RW Baird... VOC Energy Trust (VOC) downgraded at RBC Capital... Yelp (YELP) downgraded to Hold from Buy at Stifel.
07:34 EDTUFSDomtar sees Q4 paper shipments declining due to seasonality
Subscribe for More Information
07:33 EDTUFSDomtar reports Q3 adjusted EPS 94c, consensus 82c
Subscribe for More Information
07:25 EDTMERCMercer downgraded at Credit Suisse
As previously reported, Credit Suisse downgraded Mercer to Neutral from Outperform. The firm downgraded shares based on valuation. Price target is $12.
06:06 EDTMERCMercer downgraded to Neutral from Outperform at Credit Suisse
Subscribe for More Information
October 22, 2014
06:44 EDTPANWU.S. weighing cybersecurity requirements for bank vendors, NY Times says
Subscribe for More Information
October 21, 2014
07:30 EDTPANWPalo Alto price target raised to $115 from $100 at Oppenheimer
Oppenheimer raised its price target for Palo Alto Networks shares to $115 after meeting with management and reiterates an Outperform rating on the stock. The firm thinks shares can continue to move higher as the company's fundamentals remain intact.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use